Hypercalcemia in malignant paraganglioma due to parathyroid hormone-related protein

Hormone Research

Volumn 50, Issue 4, 1998, Pages 217-221

  Loh, Keh Chuan ^a,e   Matthay, Katherine K ^a   Hoover, Margo ^c   Bracho, Francisco A ^c   Cortez, Alan B ^c   Conte, Felix A ^a   Albanese, Craig T ^a   Miller, Theodore R ^b   Price, David C ^a   Flores, Alonzo J ^d   Kaviani, Ali ^c   Shoback, Dolores ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

^d Family Medicine Group   (United States)

^e TAN TOCK SENG HOSPITAL   (Singapore)

Author keywords

Humoral hypercalcemia; Malignancy; Paraganglioma; Parathyroid hormone related protein

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; CALCIUM ION; PAMIDRONIC ACID; PARATHYROID HORMONE; PARATHYROID HORMONE RELATED PROTEIN;

ADOLESCENT; ARTICLE; CALCIUM BLOOD LEVEL; CASE REPORT; HUMAN; HYPERCALCEMIA; INTRAVENOUS DRUG ADMINISTRATION; MALE; PARAGANGLIOMA; PARATHYROID HORMONE BLOOD LEVEL; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RETROPERITONEAL CANCER;

EID: 0031743059     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000023277     Document Type: Article

References (23)

1. Ali IM, Graham C, Sanalla B, Bell D: Carotid body tumor associated with hyperparathyroidism. Ann Vasc Surg 1994;8:595-598.
2. White MC, Hickson BR: Multiple paragangliomata secreting catecholamines and calcitonin with intermittent hypercalcaemia. J R Soc Med 1979;72:532-538.
3. Passwell J, Boichis H, Lotan D, David R, Theodor R, Cohen BE, Many M: The metabolic effects of excess noradrenaline secretion from a pheochromocytoma. Am J Dis Child 1977;131:1011-1014.
4. Stewart AF, Hoecker JL, Mallette LE, Segre GV, Amatruda TT Jr, Vignery A: Hypercalcemia in pheochromocytoma. Evidence for a novel mechanism. Ann Intern Med 1985;102:776-779.
5. Burtis WJ, Wu T, Bunch C, Wysolmerski JJ, Insogna KL, Weir EC, Broadus AE, Stewart AF: Identification of a novel 17,000-dalton parathyroid hormone-like adenylate cyclase-stimulating protein from a tumor associated with humoral hypercalcemia of malignancy. J Biol Chem 1987;262:7151-7156.
6. Moseley JM, Kubota M, Diefenbach-Jagger H, Wettenhall RE, Kemp BE, Suva LJ, Rodda CP, Ebeling PR, Hudson PJ, Zajac JD, et al: Parathyroid hormone-related protein purified from a human lung cancer cell line. Proc Natl Acad Sci USA 1987;84:5048-5052.
7. Strewler GJ, Stern PH, Jacobs JW, Eveloff J, Klein RF, Leung SC, Rosenblatt M, Nissenson RA: Parathyroid hormonelike protein from human renal carcinoma cells. Structural and functional homology with parathyroid hormone. J Clin Invest 1987;80:1803-1807.
8. Kimura S, Nishimura Y, Yamaguchi K, Nagasaki K, Shimada K, Uchida H: A case of pheochromocytoma producing parathyroid-related protein and presenting with hypercalcemia. J Clin Endocrinol Metab 1990;70:1559-1563.
9. Bridgewater JA, Ratcliffe WA, Bundred NJ, Owens CWI: Malignant phaeochromocytoma and hypercalcaemia. Postgrad Med J 1993;69:77-79.
10. Suva LJ, Winslow GA, Wettenhall REH, Hammonds RG, Moseley JM, Diefenbach-Jagger H, Rodda CP, Kemp BE, Rodriguez H, Chen EY, et al: A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science 1987;237:893-896.
11. Juppner H, Abou-Samra AB, Freeman M, Kong XF, Schipani E, Richards J, Kolakowski LF Jr, Hock J, Potts JT Jr, Kronenberg MM, et al: A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide. Science 1991;254:1024-1026.
12. Budayr AA, Nissenson RA, Klein RF, Pun KK, Clark OH, Diep D, Arnaud CD, Strewler GJ: Increased levels of a parathyroid hormone-like protein in malignancy-associated hypercalcemia. Ann Intern Med 1989;111:807-812.
13. Burtis WJ, Brady TG, Orloff JJ, Ersbak JB, Warrell RP Jr, Olson BR, Wu TL, Mitnick BE, Broadus AE, Stewart AF: Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer. N Engl J Med 1990;322:1106-1112.
14. Grill V, Ho P, Body JJ, Johanson N, Lee SC, Kukreja SC, Moseley JM, Martin TJ: Parathyroid hormone-related protein: Elevated levels in both humoral hypercalcemia of malignancy and hypercalcemia complicating metastatic breast cancer. J Clin Endocrinol Metab 1991;73:1309-1315.
15. Mune T, Katakami H, Kato Y, Yasuda K, Matsukara S, Miura K: Production and secretion of parathyroid hormone-related protein in pheochromocytoma: Participation of an α-adrenergic mechanism. J Clin Endocrinol Metab 1993;76:757-762.
16. Stewart AF, Horst R, Deftos LJ, Cadman EC, Lang R, Broadus AE: Biochemical evaluation of patients with cancer-associated hypercalcemia. Evidence for humoral and nonhumoral groups. N Engl J Med 1980;303:1377-1383.
17. Schilling T, Pecherstorfer M, Blind E, Leidig G, Ziegler R, Raue F: Parathyroid hormone-related protein (PTHrP) does not regulate 1,25-dihydroxyvitamin D serum levels in hypercalcemia of malignancy. J Clin Endocrinol Metab 1993;76:801-803.
18. Schweitzer DH, Hamdy NAT, Frolich M, Zwinderman AH, Papapoulos SE: Malignancy-associated hypercalcemia: resolution of controversies over vitamin D metabolism by a pathophysiological approach to the syndrome. Clin Endocrinol 1994;41:251-256.
19. Wimalawansa SJ: Hypercalcaemia in malignancy: aetiology, pathophysiology, and its clinical management. Rev Endocr Rel Cancer 1993;45:5-24.
20. Gurney H, Grill V, Martin TJ: Parathyroid hormone-related protein and response to pamidronate in tumor-induced hypercalcaemia. Lancet 1993;341:1611-1613.
21. Wimalawansa SJ: Significance of plasma PTH-rp in patients with hypercalcemia of malignancy treated with biphosphonate. Cancer 1994; 73:2223-2230.
22. Walls J, Ratcliffe WA, Howell A, Hundred NJ: Response to intravenous biphosphonate therapy in hypercalcemic patients with and without bone metastases: The role of parathyroid hormone-related protein. Br J Cancer 1994;70:169-172.
23. Pecherstorfer M, Schilling T, Blind E, Zimmer-Roth I, Baumgartner G, Ziegler R, Raue F: Parathyroid hormone-related protein and life expectancy in hypercalcemic cancer patients. J Clin Endocrinol Metab 1994;78:1268-1270.